Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer: A European organization for research and treatment of cancer breast cancer cooperative group study

被引:35
作者
Clahsen, PC
vandeVelde, CJH
Julien, JP
Floiras, JL
Delozier, T
Mignolet, FY
Sahmoud, TM
机构
[1] UNIV LEIDEN HOSP, DEPT SURG, 2300 RC LEIDEN, NETHERLANDS
[2] EUROPEAN ORG RES TREATMENT CANC, CTR DATA, BRUSSELS, BELGIUM
[3] CTR HENRI BECQUEREL, F-76038 ROUEN, FRANCE
[4] CTR RENE HUGUENIN, ST CLOUD, FRANCE
[5] CTR FRANCOIS BACLESSE, F-14021 CAEN, FRANCE
关键词
D O I
10.1200/JCO.1996.14.3.745
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate whether a short intensive course of perioperative polychemotherapy can change the course of early breast cancer. Patients and Methods: A total of 2,795 women with early breast cancer, stage I to IIIA, were randomized onto a trial (European Organization for Research and Treatment of Cancer [EORTC] 10854) to compare surgery followed by one course of perioperative chemotherapy versus surgery alone. Patients assigned to the chemotherapy arm received one course of fluorouracil 600 mg/m(2), doxorubicin 50 mg/m(2), and cyclophosphamide 600 mg/m(2) (FAG) intravenously, within 24 hours after surgery. In both randomized treatment arms, a recommendation was made for premenopausal women with positive axillary nodes to receive prolonged courses of cyclophosphamide, methotrexate, and fluorouracil (CMF), according to the standard treatment for this subgroup. Results: At a median follow-up time of 41 months, local control was significantly better in the perioperative treatment arm as compared with the observation arm (hazards ratio, 0.60; 95% confidence interval, 0.44 to 0.83; P < .01). Disease-free survival was significantly prolonged in the chemotherapy arm (hazards ratio, 0.84; 95% confidence interval, 0.70 to 0.99; P = .04). Premenopausa node-negative patients especially showed an advantage for the perioperative chemotherapy arm. No advantage for perioperative chemotherapy was observed in premenopausal node-positive women who also had received prolonged chemotherapy. Conclusion: We conclude that one course of perioperative FAC is able to improve local control and can prolong disease-free survival in women with early breast cancer. However, our results also suggest that a perioperative timing cannot improve the results of standard prolonged chemotherapy in premenopausal women with positive axillary nodes.
引用
收藏
页码:745 / 753
页数:9
相关论文
共 39 条
  • [11] FISHER B, 1983, CANCER RES, V43, P1488
  • [12] FISHER B, NSABP PROTOCOL B 18
  • [13] GOLDHIRSCH A, 1989, NEW ENGL J MED, V320, P491
  • [14] GOLDHIRSCH A, 1987, LANCET, V2, P151
  • [15] GOLDHIRSCH A, 1983, LANCET, V2, P542
  • [16] GOLDHIRSCH A, 1988, NEW ENGL J MED, V319, P677
  • [17] GOLDHIRSCH A, 1992, MONOGR NATL CANC I, V11, P89
  • [18] GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727
  • [19] GOLDIE JH, 1984, CANCER RES, V44, P3643
  • [20] GUNDUZ N, 1979, CANCER RES, V39, P3861